A Study Of Elecsys IGRA TB Test System

Overview

About this study

The purpose of this study is to investigate the clinical performance of Elecsys IGRA TB Test System in detecting Mycobacterium tuberculosis (M. tb) infections in adult patients with active TB and individuals with or without known risk factors of latent M. tb infections.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Participants were enrolled prospectively under the RD007067 sample collection study protocol ”Sample Collection for Elecsys IGRA TB Test System” and vendor(s) prospective collection protocol(s).

Exclusion Criteria:

  • None

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/10/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elitza Theel

Contact us for the latest status

Contact information:

Elitza Theel

(507) 284-3743

Theel.Elitza@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597200

Mayo Clinic Footer